Free Trial
OTCMKTS:GNWSD

StageZero Life Sciences (GNWSD) Stock Price, News & Analysis

StageZero Life Sciences logo
$0.0021 0.00 (0.00%)
As of 03/11/2025

About StageZero Life Sciences Stock (OTCMKTS:GNWSD)

Key Stats

Today's Range
$0.0021
$0.0021
50-Day Range
$0.00
$0.04
52-Week Range
$0.17
$0.89
Volume
N/A
Average Volume
4,987 shs
Market Capitalization
$102,774.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall in 1998 and is headquartered in Markham, Canada.

Remove Ads
Receive GNWSD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

GNWSD Stock News Headlines

DOGE’s Next Move: Not what you think
Donald Trump, Elon Musk and the Department of Government Efficiency have kept their word. Moving even faster than most people thought … Clearing out waste and inefficiency in our government.
See More Headlines

GNWSD Stock Analysis - Frequently Asked Questions

StageZero Life Sciences' stock was trading at $0.0016 on January 1st, 2025. Since then, GNWSD stock has increased by 31.3% and is now trading at $0.0021.
View the best growth stocks for 2025 here
.

Shares of GNWSD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:GNWSD
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,480,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$140,000.00
Price / Cash Flow
N/A
Book Value
($0.13) per share
Price / Book
-0.02

Miscellaneous

Free Float
N/A
Market Cap
$102,774.00
Optionable
Not Optionable
Beta
2.97
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (OTCMKTS:GNWSD) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners